Gastroresistant pharmaceutical dosage form comprising N-(2-(2-phthalimidoethoxy)-acetyl)-L-alanyl-D-glutamic acid (LK-423)

The present invention relates to the pharmaceutical dosage forms which enable a controlled and/or a targeted delivery of an active substance to the selected regions of gastrointestinal tract of humans or animals. The pharmaceutical dosage forms preferably comprises the active substance N-(2(2-phthal...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	TATJANA MATEOVIC, DORIS TIBAUT, SHIZUKO MURAOKA, GRETA COF, ANTON STALC, JANEZ KERK, MARIJA BOGATAJ, FUMIO YONEDA, ROK DREU, ANTON LAVRIC, UROS URLEB, ALES MRHAR, MANICA CERNE
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!